Form 4: Metagenomi Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Matthew Wein, a Metagenomi executive, sold 930 shares of common stock on March 5, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 5, 2025, Matthew Wein, Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary of Metagenomi, Inc. (MGX), sold 930 shares of common stock.
- The sale was executed to satisfy tax withholding obligations upon the vesting of restricted stock units.
- The shares were sold at a weighted average price of $1.8748, with individual transactions ranging from $1.85 to $1.90.
- Following the transaction, Wein beneficially owns 9,467 shares of Metagenomi common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and doesn't inherently indicate positive or negative sentiment regarding the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. This provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale (tax obligations).
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of grant of restricted stock units to the reporting person. |
| 03/05/2025 | Date of the transaction (stock sale). |
| 03/07/2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.